1 |
Artesunate
| 1件: Artesunate Artesunate | 1件: D02482
D02482
| - | - | 6件: 18 18, 53, 66, 96, 215, 271 |
2 |
Baclofen
| 2件: Baclofen Baclofen; Kemstro | 1件: D00241
D00241
| 2件: GABBR1 GABBR1, GABBR2 💬 | 7件: Estrogen signaling pathway Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬 | 8件: 2 2, 10, 13, 18, 65, 70, 149, 206 |
3 |
Bupropion
| 2件: Bupropion Bupropion; Bupropion Hydrochloride | 1件: D07591
D07591
| 2件: SLC6A2 SLC6A2, SLC6A3 💬 | 7件: Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Parkinson disease, Pathways of neurodegeneration - multiple diseases, Synaptic vesicle cycle 💬 | 5件: 8 8, 18, 21, 96, 171 |
4 |
Butylphthalide
| 1件: Butylphthalide Butylphthalide | - | - | - | 4件: 2 2, 6, 18, 22 |
5 |
Calcitriol
| 1件: Calcitriol Calcitriol | 1件: D00129
D00129
| 1件: VDR VDR 💬 | 5件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Mineral absorption, Parathyroid hormone synthesis, secretion and action, Tuberculosis 💬 | 9件: 18 18, 37, 46, 49, 66, 96, 158, 235, 326 |
6 |
Carbonate ion
| 1件: Carbonate Carbonate | - | - | - | 12件: 2 2, 13, 17, 18, 19, 46, 53, 75, 96, 127, 235, 299 |
7 |
Citalopram
| 1件: Citalopram Citalopram | 1件: D07704
D07704
| 1件: SLC6A4 SLC6A4 💬 | 2件: Serotonergic synapse Serotonergic synapse, Synaptic vesicle cycle 💬 | 7件: 6 6, 8, 13, 18, 46, 98, 127 |
8 |
CTI-1601
| 1件: CTI-1601 CTI-1601 | - | - | - | 1件: 18 18 |
9 |
Deferiprone
| 2件: Deferiprone Deferiprone; Ferriprox | 1件: D07416
D07416
| - | - | 6件: 2 2, 6, 18, 120, 122, 233 |
10 |
Erythropoietin
| 4件: Epoetin alfa Epoetin alfa; Epoetin beta; Erythropoietin; NeoRecormon | - | - | - | 10件: 2 2, 6, 13, 18, 22, 46, 47, 70, 95, 96 |
11 |
Etravirine
| 3件: ETRAVIRINA ETRAVIRINA; Etravirine; INTELENCE | 1件: D04112
D04112
| - | - | 1件: 18 18 |
12 |
Flumazenil
| 1件: Flumazenil Flumazenil | 1件: D00697
D00697
| 16件: GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | 7件: GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | 5件: 6 6, 13, 17, 18, 206 |
13 |
Ginkgo biloba
| 3件: Ginkgo Ginkgo; Ginkgo biloba; Tanakan | - | - | - | 5件: 6 6, 13, 18, 47, 90 |
14 |
Idebenone
| 2件: Idebenone Idebenone; Raxone | 1件: D01750
D01750
| - | - | 6件: 6 6, 8, 13, 18, 113, 302 |
15 |
Interferon Gamma
| 1件: Interferon Gamma Interferon Gamma | - | - | - | 8件: 18 18, 65, 85, 107, 228, 299, 301, 326 |
16 |
Interferon gamma-1b
| 2件: ACTIMMUNE ACTIMMUNE; Interferon Gamma-1B | 1件: D00747
D00747
| 2件: IFNGR1 IFNGR1, IFNGR2 💬 | 18件: Chagas disease Chagas disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways in cancer, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis 💬 | 7件: 18 18, 65, 85, 228, 299, 301, 326 |
17 |
Iron
| 1件: Iron Iron | - | - | - | 6件: 18 18, 96, 97, 238, 254, 284 |
18 |
Lenograstim
| 2件: G-CSF G-CSF; Lenograstim | 1件: D03247
D03247
| 1件: CSF3R CSF3R 💬 | 5件: Cytokine-cytokine receptor interaction Cytokine-cytokine receptor interaction, Hematopoietic cell lineage, JAK-STAT signaling pathway, PI3K-Akt signaling pathway, Pathways in cancer 💬 | 7件: 2 2, 13, 16, 18, 19, 57, 65 |
19 |
Lithium carbonate
| 2件: Lithium Lithium; LITHIUM CARBONATE | 1件: D00801
D00801
| - | - | 5件: 2 2, 13, 17, 18, 127 |
20 |
Methylprednisolone
| 4件: Medrol Medrol; Methylprednisolon; Methylprednisolone; METHYLPREDNISOLONE ACETATE | 1件: D00407
D00407
| 1件: NR3C1 NR3C1 💬 | 1件: Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | 46件: 2 2, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 95, 96, 97, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296 |
21 |
Nicotinamide
| 3件: Multivitamin Multivitamin; Niacinamide; Nicotinamide | 1件: D00036
D00036
| - | - | 10件: 2 2, 5, 6, 18, 49, 67, 97, 107, 162, 191 |
22 |
Nicotinamide riboside
| 1件: Nicotinamide Riboside Nicotinamide Riboside | - | - | - | 5件: 2 2, 6, 18, 97, 191 |
23 |
Omaveloxolone
| 1件: Omaveloxolone Omaveloxolone | 1件: D10964
D10964
| 1件: NFE2L2 NFE2L2 💬 | 7件: Chemical carcinogenesis - reactive oxygen species Chemical carcinogenesis - reactive oxygen species, Fluid shear stress and atherosclerosis, Hepatocellular carcinoma, Lipid and atherosclerosis, Parkinson disease, Pathways in cancer, Protein processing in endoplasmic reticulum 💬 | 1件: 18 18 |
24 |
Resveratrol
| 1件: Resveratrol Resveratrol | - | - | - | 6件: 2 2, 8, 18, 89, 97, 113 |
25 |
Riluzole
| 2件: Rilutek Rilutek; Riluzole | 1件: D00775
D00775
| 14件: GRIA1 GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 | 23件: Alcoholism Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term depression, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Retrograde endocannabinoid signaling, Spinocerebellar ataxia, Systemic lupus erythematosus, Transcriptional misregulation in cancer, cAMP signaling pathway 💬 | 9件: 2 2, 3, 5, 8, 13, 17, 18, 203, 206 |
26 |
Rosuvastatin
| 3件: Crestor Crestor; Rosuvastatin; Rosuvastatin calcium | 1件: D08492
D08492
| 1件: HMGCR HMGCR 💬 | 4件: AMPK signaling pathway AMPK signaling pathway, Bile secretion, Metabolic pathways, Terpenoid backbone biosynthesis 💬 | 11件: 6 6, 18, 46, 49, 51, 56, 79, 96, 97, 271, 299 |
27 |
TAK-831
| 1件: TAK-831 TAK-831 | - | - | - | 1件: 18 18 |
28 |
Trehalose
| 2件: Cabaletta Cabaletta; Trehalose | - | - | - | 4件: 2 2, 6, 18, 113 |
29 |
Ubidecarenone
| 3件: Coenzyme Q-10 Coenzyme Q-10; Coenzyme Q10; CoQ10 | 1件: D01065
D01065
| - | - | 12件: 2 2, 5, 6, 8, 10, 18, 46, 57, 86, 113, 214, 215 |
30 |
Varenicline
| 2件: Champix Champix; Varenicline | 1件: D08669
D08669
| 2件: CHRNA4 CHRNA4, CHRNB2 💬 | 4件: Chemical carcinogenesis - receptor activation Chemical carcinogenesis - receptor activation, Cholinergic synapse, Neuroactive ligand-receptor interaction, Nicotine addiction 💬 | 3件: 6 6, 18, 53 |
31 |
Vatiquinone
| 1件: VATIQUINONE VATIQUINONE | 1件: D10407
D10407
| - | - | 2件: 18 18, 21 |